Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer

Launched by DAPING HOSPITAL AND THE RESEARCH INSTITUTE OF SURGERY OF THE THIRD MILITARY MEDICAL UNIVERSITY · Apr 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new surgical method called Transoral Vestibular Robotic Thyroidectomy (TOVRT) for treating thyroid cancer. The trial compares this approach to the traditional open surgery used for thyroid cancer. The main goal is to see if TOVRT is just as effective as the standard method, while also being less invasive. This means patients may experience shorter hospital stays and have better cosmetic results since the surgery is done through the mouth, leaving no visible scars on the neck.

To participate in this trial, you need to be between 18 and 65 years old and diagnosed with a specific type of thyroid cancer called papillary thyroid carcinoma. Unfortunately, if your condition is benign (not cancerous) or if your medical information is incomplete, you won't be able to join. If eligible, participants can expect to undergo robotic surgery and will help researchers learn more about this innovative technique, especially for smaller tumors. This trial is important as it could lead to new, less invasive options for patients with thyroid cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18- 65 years old, both male and female
• • Postoperative pathology was papillary thyroid carcinoma
• • Clinical data integrity
• Exclusion Criteria:
• • Postoperative pathology was benign
• • Clinical data are incomplete